| Conferences \ BioProcessing, Biologics & Biotherapeutics Congress \ Antibody and Peptide Therapeutics \ Agenda \ Matthew Baker |
| Register | Login |
Background and Key Drivers Leading to Clinical ImmunogenicityThursday, 21 July 2011 at 11:45  Add to Calendar ▼2011-07-21 11:45:002011-07-21 12:45:00Europe/LondonBackground and Key Drivers Leading to Clinical Immunogenicity SELECTBIOenquiries@selectbiosciences.com• Data showing in silico and in vitro T cell epitope identification technologies employed at various stages of the development pipeline to help optimise pre-clinical decision making • Specific examples where these technologies have been used for the detection of immunogenicity • Solutions for the rational design and engineering of protein therapeutics to reduce the risk of immunogenicity |
Add to Calendar ▼2011-07-20 00:00:002011-07-21 00:00:00Europe/LondonAntibody and Peptide TherapeuticsSELECTBIOenquiries@selectbiosciences.com
